SECOND AMENDMENT TO LOAN AGREEMENTLoan Agreement • November 6th, 2014 • XOMA Corp • Pharmaceutical preparations • New York
THIS SECOND AMENDMENT TO LOAN AGREEMENT (this “Amendment”) is entered into as of August 12, 2013, by and among XOMA (US) LLC, a Delaware limited liability company (“Borrower”); XOMA CORPORATION (formerly known as XOMA Ltd.), a Delaware corporation (“Holdings”); the other Loan Parties signatory hereto; GENERAL ELECTRIC CAPITAL CORPORATION, a Delaware corporation (in its individual capacity, “GE Capital”), for itself as Lender and as Agent for Lenders; and the other Lenders signatory hereto.
THIRD AMENDMENT AND CONSENT TO LOAN AGREEMENTLoan Agreement • November 6th, 2014 • XOMA Corp • Pharmaceutical preparations • New York
THIS THIRD AMENDMENT TO LOAN AGREEMENT (this “Amendment”) is entered into as of August 22, 2014 and effective as of August 18, 2014, by and among XOMA (US) LLC, a Delaware limited liability company (“Borrower”); XOMA CORPORATION (formerly known as XOMA Ltd.), a Delaware corporation (“Parent”); the other Loan Parties signatory hereto; GENERAL ELECTRIC CAPITAL CORPORATION, a Delaware corporation (in its individual capacity, “GE Capital”), for itself as Lender and as Agent for Lenders; and the other Lenders signatory hereto.
First Amendment to the License Agreement effective as of December 29, 2003 between XOMA Ireland Limited and Diversa CorporationLicense Agreement • November 6th, 2014 • XOMA Corp • Pharmaceutical preparations
This first amendment ("First Amendment") to the License Agreement effective as of December 29, 2003 between XOMA Ireland Limited (assigned to XOMA (US) LLC) and Verenium Corporation (formerly known as Diversa Corporation and assigned to BP) (the "Agreement") is entered into by and between XOMA (US) LLC, a Delaware company with limited liability ("XOMA"), and BP Biofuels Advanced Technology Inc., a Delaware corporation ("BP") on October 28, 2014 (the "First Amendment Effective Date").
